- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Alternative Capital and Credit Funds
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions
- Middle East and Islamic Finance and Investment
- Private Equity
- Real Estate
- Securitization
- Tax
- Technology and Emerging Companies
- Government Matters
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Insurance Coverage and Recovery
- Intellectual Property, Patent, Trademark and Copyright Litigation
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries
- Careers
- News & Insights
- About
- Languages
Insight 20 results
Newsletter
February 22, 2019
Autonomous Vehicles Speed Read – February 2019
Thought Leadership
February 1, 2019
Selected Takeaways From King & Spalding’s 11th Annual Pharmaceutical University
Newsletter
January 18, 2019
Autonomous Vehicles Speed Read - January 2019
Newsletter
December 19, 2018
Autonomous Vehicles Speed Read - December 2018
Newsletter
November 15, 2018
Autonomous Vehicles Speed Read - November 2018
Newsletter
October 19, 2018
Autonomous Vehicles Speed Read - October 2018
Newsletter
September 27, 2018
Autonomous Vehicles Speed Read
Article · Source: Law360 (Product Liability)
June 20, 2018
Tips for Keeping FDA Advisory Action Letters Out of Court
Article · Source: The Law Reviews
June 13, 2018
The Product Regulation and Liability Review – 5th Edition
Article · Source: OUP Oxford
January 18, 2018
Drug and Device Product Liability Litigation Strategy
Article · Source: American Bar Association
October 1, 2017
Admissibility of Expert Evidence to Prove Causation in Toxic Torts
Article · Source: Law360
June 15, 2017
High Court's Superficial Analysis In Biosimilars Ruling